ArticleSurgical endoscopy2026
Feasibility of a tubeless enhanced recovery strategy in non-high-risk patients undergoing laparoscopy-assisted gastrectomy for gastric cancer.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundAlthough nasogastric decompression, nasojejunal feeding, and abdominal drainage tubes are not routinely recommended in Enhanced Recovery After Surgery (ERAS) guidelines for gastrectomy, evidence regarding the avoidance of any inserted tubes after laparoscopic gastrectomy remains limited. This study aimed to evaluate the short-term feasibility and clinical outcomes of an ERAS-tubeless protocol in gastric cancer patients undergoing non-high-risk laparoscopy-assisted gastrectomy.
methodsAt a high-volume center, eligible patients of gastric cancer (cT1-4N0-3M0) who lacked protocol-defined high-risk features were enrolled in this prospective non-randomized controlled study. Patients were allocated to either the ERAS-tubeless group or the ERAS-tube group at a predefined 1:1 ratio according to a team-level allocation protocol. All patients underwent laparoscopy-assisted gastrectomy following strict and consistent quality control standards and received distinct ERAS-based postoperative tube-management strategies. The primary outcome was postoperative hospital stay, and secondary outcomes included postoperative quality of life scores and the incidence of complications.
resultsBetween March 2023 and September 2024, 220 patients were allocated, and 205 were included in the per-protocol population after post-allocation exclusions. The ERAS-tubeless group had a shorter mean postoperative hospital stay (6.0 vs. 7.3 days; P < 0.001). After Benjamini-Hochberg adjustment for multiple comparisons, QoR-15 scores remained significantly higher on postoperative days 1 and 3. For the EORTC QLQ-C30, significant between-group differences persisted in global health and QoL, emotional functioning, and social functioning domains. No increase in the incidence of early postoperative complications was observed; however, the study was underpowered to exclude rare but serious adverse events.
conclusionsIn non-high-risk patients with gastric cancer, implementation of the ERAS-tubeless strategy following laparoscopy-assisted gastrectomy under a rigorous surgical quality control system can facilitate postoperative recovery, enhance patient experience, and not increase the risk of early postoperative complications, which warrants further validation.
Indexed as
Identifiers
42864454What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.